fashion -WSS

fashion

author：entertainment 2025-09-28 00:51:26 - browse：42941

Mayo Clinic, in Rochester, Minnesota on — Photo by KEREM YUCEL/AFP via Getty Images

SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： What we owe ALS patients — and why one company fell short

WSS

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Curing rare childhood diseases will falter unless Congress steps up

STAT Virtual Event: ASCO Recap, Live!

What we owe ALS patients — and why one company fell short

Moderna says combo Covid

The biotech scorecard for Q4: 16 stock

knowledge

fashion

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Statins may not be needed by millions of people, study suggests

Alkermes shareholders re

How faith leaders like me can help address America's obesity epidemic

Moonlake's readout produced a cash windfall. Risks remain

Stop Congress from blocking public access to science

BioMarin wins approval for gene therapy to treat hemophilia A

Pharma companies must ensure equitable access to obesity drugs

23andMe had bad news about my health. I wish a person had delivered it

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

hotspot

European officials brace for rough respiratory virus season

Curing rare childhood diseases will falter unless Congress steps up

STAT Virtual Event: ASCO Recap, Live!

Nobel honors Karikó and Weissman's enduring partnership

How faith leaders like me can help address America's obesity epidemic

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

hotspot

leisure time

focus

hotspot